Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives

Autoimmun Rev. 2020 Nov;19(11):102662. doi: 10.1016/j.autrev.2020.102662. Epub 2020 Sep 14.

Abstract

Systemic Sclerosis is chronic progressive autoimmune disease, characterised by microangiopathy and fibrosis. Due to disease heterogeneity, in terms of extent, severity, and rate of progression, optimal therapeutic interventions are still lacking. Haematopoietic stem cells may be a new therapeutic option in this disease and, although the results of the first trials are encouraging, several issues remain to be addressed. On these bases, the stem cells transplantation is an area of active investigation, and an overview of the current available literature may help to define the role of this therapeutic strategy. Although the promising results, some unmet needs remain, including the transplantation protocols and their effects on immune system, the selection of the ideal patient and the pre-transplant cardiopulmonary evaluations. An improvement in these fields will allow us to optimize the haematopoietic stem cell therapies in SSc.

Keywords: Haematopoietic stem cells transplantation; Systemic sclerosis.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells
  • Humans
  • Scleroderma, Systemic* / therapy